KMDA : Summary for Kamada Ltd. - Ordinary Shares - Yahoo Finance

U.S. Markets open in 4 hrs 11 mins

Kamada Ltd. (KMDA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.05-0.05 (-0.70%)
At close: 4:00PM EST
People also watch
RDHLEVGNMZORADHDENZY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close7.10
Open7.05
Bid6.50 x 100
Ask7.60 x 100
Day's Range7.00 - 7.15
52 Week Range3.26 - 7.25
Volume7,382
Avg. Volume12,262
Market Cap255.56M
BetaN/A
PE Ratio (TTM)-38.11
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Kamada Ltd. :KMDA-US: Earnings Analysis: 2016 By the Numbers : February 9, 2017
    Capital Cube12 days ago

    Kamada Ltd. :KMDA-US: Earnings Analysis: 2016 By the Numbers : February 9, 2017

    Categories: Yahoo Finance Get free summary analysis Kamada Ltd. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Kamada Ltd. – Vertex Pharmaceuticals Incorporated (VRTX-US) that have also reported for this period. Highlights Gross margins widened from 21.85% to 27.94% compared to the same period last year, ... Read more (Read more...)

  • GlobeNewswire13 days ago

    Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors

    NESS ZIONA, Israel, Feb. 08, 2017-- Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announced today the appointment of Gwen A. Melincoff to the Company’ s Board ...

  • Associated Press15 days ago

    Kamada reports 4Q loss

    The Ness Ziona, Israel-based company said it had a loss of 5 cents per share. The biopharmaceutical posted revenue of $24.3 million in the period. For the year, the company reported that its loss narrowed ...